Management of perianal Crohn's disease

Current Treatment Options in Gastroenterology

Volumn 8, Issue 3, 2005, Pages 197-209

  Person, Benjamin ^a   Wexner, Steven D ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ALCOHOL; ALLOPURINOL; ALUMINUM; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIMETABOLITE; ATLIZUMAB; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; BOTULINUM TOXIN; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CERTOLIZUMAB PEGOL; CHLORAMBUCIL; CIPROFLOXACIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIN GLUE; GLYCERYL TRINITRATE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 6 RECEPTOR; ISOSORBIDE DINITRATE; LIDOCAINE; LITHIUM; MAGNESIUM; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; MEVINOLIN; NATALIZUMAB; NIFEDIPINE; PHENYTOIN; PROBIOTIC AGENT; RECEPTOR ANTIBODY; SKIN PROTECTIVE AGENT; THEOPHYLLINE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; WARFARIN;

ABDOMINAL PAIN; ABSCESS DRAINAGE; ANOREXIA; ANUS CONTINENCE; ANUS DISEASE; ANUS FISSURE; ANUS FISTULA; CANCER; CHOLESTASIS; CLINICAL TRIAL; CONVULSION; CROHN DISEASE; DELAYED HYPERSENSITIVITY; DIARRHEA; DIET THERAPY; DIGITALIS INTOXICATION; DIZZINESS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ESOPHAGITIS; FECES INCONTINENCE; FEVER; GINGIVA HYPERPLASIA; GLOSSITIS; HALLUCINATION; HEADACHE; HEMATOCHEZIA; HEMORRHOID; HEPATITIS; HIRSUTISM; HUMAN; HYPERKALEMIA; HYPERTENSION; INFECTION RATE; INFLAMMATION; INSOMNIA; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LEUKOPENIA; LIFESTYLE; LIVER TOXICITY; MEGALOBLASTIC ANEMIA; MILIARY TUBERCULOSIS; MYOSITIS; NAUSEA; NEPHROTOXICITY; NEUROLOGIC DISEASE; OPPORTUNISTIC INFECTION; PANCREATITIS; PANCYTOPENIA; PARESTHESIA; PERIANAL ABSCESS; PERIPHERAL NEUROPATHY; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PROCTITIS; PSYCHOSIS; RASH; RECTUM RESECTION; REVIEW; SEIZURE; SEPSIS; SIDE EFFECT; SPHINCTEROTOMY; SURGICAL TECHNIQUE; SYSTEMIC LUPUS ERYTHEMATOSUS; TASTE DISORDER; TREMOR; VOMITING; WOUND CARE;

EID: 21044442848     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-005-0012-1     Document Type: Review

References (80)

1. Crohn BB, Ginzburg L, Oppenheimer GD: Regional ileitis, a pathological and clinical entity. JAMA 1932, 99:1323-1329.
2. Bissell AD: Localized chronic ulcerative colitis. Ann Surg 1934, 99:957-966.
3. Penner A, Crohn BB: Perianal Fistulae as a complication of regional ileitis. Ann Surg 1938, 108:867-873.
4. Buchmann P, Alexander-Williams J: Classification of perianal Crohn's disease. Clin Gastroenterol 1980, 9:323-330.
5. Hughes LE: Surgical pathology and management of anorectal Crohn's disease. J R Soc Med 1978, 71:644-651.
6. Alexander-Williams J: Fistula-in-ano: management of Crohn's fistula. Dis Colon Rectum 1976, 19:518-519.
7. Lockhart-Mummery HE: Symposium. Crohn's disease: anal lesions. Dis Colon Rectum 1975, 18:200-202.
8. Sangwan YP, Schoetz DJ Jr, Murray JJ, et al.: Perianal Crohn's disease. Results of local surgical treatment. Dis Colon Rectum 1996, 39:529-535.
9. Alabaz O, Weiss EG: Anorectal Crohn's Disease. In Fundamentals of Anorectal Surgery, 2nd ed. Edited by Beck D, Wexner SD. Philadelphia: WB Saunders; 1999: 498-509.
10. Singh B, McC Mortensen NJ, Jewell DP, George B: Perianal Crohn's disease. Br J Surg 2004, 91:801-814.
11. Homan WP, Tang C, Thorgjarnarson B: Anal lesions complicating Crohn's disease. Arch Surg 1976, 111:1333-1335.
12. Wolkomir AF, Luchtefeld MA: Surgery for symptomatic hemorrhoids and anal fissures in Crohn's disease. Dis Colon Rectum 1993, 36:545-547.
13. Jeffery PJ, Parks AG, Ritchie JK: Treatment of haemorrhoids in patients with inflammatory bowel disease. Lancet 1977, 1:1084-1085.
14. Buchmann P, Keighley MR, Allan RN, et al.: Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism. Am J Surg 1980, 140:642-644.
15. Linares L, Moreira LF, Andrews H, et al.: Natural history and treatment of anorectal strictures complicating Crohn's disease. Br J Surg 1988, 75:653-655.
16. Makowiec F, Jehle EC, Becker HD, Starlinger M: Perianal abscess in Crohn's disease. Dis Colon Rectum 1997, 40:443-450.
17. Schwartz DA, Pemberton JH, Sandborn WJ: Diagnosis and treatment of perianal fistulas in Crohn disease. Ann Intern Med 2001, 135:906-918.
18. Fry RD, Shemesh EI, Kodner IJ, Timmcke A: Techniques and results in the management of anal and perianal Crohn's disease. Surg Gynecol Obstet 1989, 168:42-48.
19. Levien DH, Surrell J, Mazier WP: Surgical treatment of anorectal fistula in patients with Crohn's disease. Surg Gynecol Obstet 1989, 169:133-136.
20. Williams JG, Rothenberger DA, Nemer FD, Goldberg SM: Fistula-in-ano in Crohn's disease. Results of aggressive surgical treatment. Dis Colon Rectum 1991, 34:378-384.
21. Lindsey I, Smilgin-Humphreys MM, Cunningham C, et al.: A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula. Dis Colon Rectum 2002, 45:1608-1615.
22. Sentovich SM: Fibrin glue for anal fistulas: long-term results. Dis Colon Rectum 2003, 46:498-502.
23. Hammond TM, Grahn MF, Lunniss PJ: Fibrin glue in the management of anal fistulae. Colorectal Dis 2004, 6:308-319.
24. White RA, Eisenstat TE, Rubin RJ, Salvati EP: Seton management of complex anorectal fistulas in patients with Crohn's disease. Dis Colon Rectum 1990, 33:587-589.
25. Koganei K, Sugita A, Harada H, et al.: Seton treatment for perianal Crohn's fistulas. Surg Today 1995, 25:32-36.
26. Faucheron JL, Saint-Marc O, Guibert L, Parc R: Long-term seton drainage for high anal fistulas in Crohn's disease - a sphincter-saving operation? Dis Colon Rectum 1996, 39:208-211.
27. Takesue Y, Ohge H, Yokoyama T, et al.: Long-term results of seton drainage on complex anal fistulae in patients with Crohn's disease. J Gastroenterol 2002, 37:912-915.
28. Makowiec F, Jehle EC, Becker HD, Starlinger M: Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn's disease. Br J Surg 1995, 82:603-606.
29. Joo JS, Weiss EG, Nogueras JJ, Wexner SD: Endorectal advancement flap in perianal Crohn's disease. Am Surg 1998, 64:147-150.
30. Mizrahi N, Wexner SD, Zmora O, et al.: Endorectal advancement flap: are there predictors of failure? Dis Colon Rectum 2002, 45:1616-1621.
31. Sonoda T, Hull T, Piedmonte MR, Fazio VW: Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap. Dis Colon Rectum 2002, 45:1622-1628.
32. Hull TL, Fazio VW: Surgical approaches to low anovaginal fistula in Crohn's disease. Am J Surg 1997, 173:95-98.
33. Hesterberg R, Schmidt WU, Muller F, Roher HD: Treatment of anovaginal fistulas with an anocutaneous flap in patients with Crohn's disease. Int J Colorectal Dis 1993, 8:51-54.
34. Robertson WG, Mangione JS: Cutaneous advancement flap closure: alternative method for treatment of complicated anal fistulas. Dis Colon Rectum 1998, 41:884-886.
35. Simmang CL, Lacey SW, Huber PJ Jr: Rectal sleeve advancement: repair of rectovaginal fistula associated with anorectal stricture in Crohn's disease. Dis Colon Rectum 1998, 41:787-789.
36. Keighley MR, Williams NS: Surgical treatment of perianal Crohn's disease. In Surgery of the Anus, Rectum and Colon, 2nd ed. Edited by Keighley MR, Williams NS. Philadelphia, PA USA. WB Saunders; 1999: 2135-2157.
37. Scott A, Hawley PR, Phillips RK: Results of external sphincter repair in Crohn's disease. Br J Surg 1989, 76:959-960.
38. Ky A, Sohn N, Weinstein MA, Korelitz BI: Carcinoma arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum 1998, 41:992-996.
39. Ezri T, Susmallian S: Topical nifedipine vs. topical glyceryl trinitrate for treatment of chronic anal fissure. Dis Colon Rectum 2003, 46:805-808.
40. Lysy J, Israelit-Yatzkan Y, Sestiery-Ittah M, et al.: Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure. Gut 2001, 48:221-224.
41. Knight JS, Birks M, Farouk R: Topical diltiazem ointment in the treatment of chronic anal fissure. Br J Surg 2001, 88:553-556.
42. Maria G, Cassetta E, Gui D, et al.: A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 1998, 338:217-220.
43. Lindsey I, Jones OM, Cunningham C, et al.: Botulinum toxin as second-line therapy for chronic anal fissure failing 0.2 percent glyceryl trinitrate. Dis Colon Rectum 2003, 46:361-366.
44. Hamling J, Raedler A, Helmchen U, Schreiber S: 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease. Digestion 1997, 58:304-307.
45. Haas M, Shetye KR: Acute renal failure in a 53-year-old woman with Crohn's disease treated with 5-aminosalicylic acid. Am J Kidney Dis 2001, 38:205-209.
46. Kotanagi H, Ito M, Koyama K, Chiba M: Pancytopenia associated with 5-aminosalicylic acid use in a patient with Crohn's disease. J Gastroenterol 1998, 33:571-4.
47. Bernstein LH, Frank MS, Brandt LJ, Boley SJ: Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980, 79:357-365.
48. Jakobovits J, Schuster MM: Metronidazole therapy for Crohn's disease and associated fistulae. Am J Gastroenterol 1984, 79:533-540.
49. Arnold GL, Beaves MR, Pryjdun VO, Mook WJ: Preliminary study of ciprofloxacin in active Crohn's disease. Inflamm Bowel Dis 2002, 8:10-15.
50. Ishikawa T, Okamura S, Oshimoto H, et al.: Metronidazole plus ciprofloxacin therapy for active Crohn's disease. Intern Med 2003, 42:318-321.
51. Pearson DC, May GR, Fick G, Sutherland LR: Azathioprine for maintaining remission of Crohn's disease. Cochrane Database Syst Rev 2000, (2):CD000067.
52. Sandborn W, Sutherland L, Pearson D, et al.: Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2000, (2):CD000545.
53. Jeshion WC, Larsen KL, Jawad AF, et al.: Azathioprine and 6-mercaptopurine for the treatment of perianal Crohn's disease in children. J Clin Gastroenterol 2000, 30:294-298.
54. Egan LJ, Sandborn WJ, Tremaine WJ: Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine. Am J Gastroenterol 1998, 93:442-448.
55. Present DH, Lichtiger S: Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig Dis Sci 1994, 39:374-380.
56. Hanauer SB, Smith MB: Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A. Am J Gastroenterol 1993, 88:646-649.
57. Present DH, Rutgeerts P, Targan S, et al.: Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999, 340:1398-1405.
58. Sands BE, Anderson FH, Bernstein CN, et al.: Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004, 350:876-885.
59. Sandborn WJ, Present DH, Isaacs KL, et al.: Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 2003, 125:380-388.
60. Sweeney JL, Ritchie JK, Nicholls RJ: Anal fissure in Crohn's disease. Br J Surg 1988, 75:56-57.
61. Fleshner PR, Schoetz DJ Jr, Roberts PL, et al.: Anal fissure in Crohn's disease: a plea for aggressive management. Dis Colon Rectum 1995, 38:1137-1143.
62. Rius J, Nessim A, Nogueras JJ, Wexner SD: Gracilis transposition in complicated perianal fistula and unhealed perineal wounds in Crohn's disease. Eur J Surg 2000, 166:218-222.
63. Yamamoto T, Allan RN, Keighley MR: Effect of fecal diversion alone on perianal Crohn's disease. World J Surg 2000, 24:1258-262.
64. Michelassi F, Melis M, Rubin M, Hurst RD: Surgical treatment of anorectal complications in Crohn's disease. Surgery 2000, 128:597-603.
65. Lavy A, Weisz G, Adir Y, et al.: Hyperbaric oxygen for perianal Crohn's disease. J Clin Gastroenterol 1994, 19:202-205.
66. Stack WA, Mann SD, Roy AJ, et al.: Randomized controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet 1997, 349:521-524.
67. Sandborn WJ, Feagan BG, Radford-Smith G, et al.: CDP571, a humanized monoclonal antibody to tumour necrosis factor alpha, for moderate to severe Crohn's disease: a randomized, double blind, placebo controlled trial. Gut 2004, 53:1485-1493.
68. Schreiber S, Rutgeerts P, Fedorak RN, et al.: CDP870, a humanized anti-TNFa antibody fragment, induces clinical response with remission in patients with active Crohn's disease. Gastroenterology 2003, 124:A468.
69. Ghosh S, Goldin E, Gordon FH, et al.: Natalizumab for active Crohn's disease. N Engl J Med 2003, 348:24-32.
70. Sandborn WJ, Hanauer S, Loftus EV Jr, et al.: An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease. Am J Gastroenterol 2004, 99:1984-1989.
71. Ito H, Takazoe M, Fukuda Y, et al.: A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 2004, 126:989-996.
72. Borruel N, Carol M, Casellas F, et al.: Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 2002, 51:659-664.
73. Fedorak RN, Madsen KL: Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 2004, 10:286-299.
74. Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126:1620-1633.
75. Dieckgraefe BK, Korzenik JR: Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet 2002, 360:1478-1480.
76. Vaughan D, Drumm B: Treatment of fistulas with granulocyte colony-stimulating factor in a patient with Crohn's disease. N Engl J Med 1999, 340:239-240.
77. Dejaco C, Lichtenberger C, Miehsler W, et al.: An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease. Digestion 2003, 68:63-70.
78. Craig RM, Traynor A, Oyama Y, Burt RK: Hematopoietic stem cell transplantation for severe Crohn's disease. Bone Marrow Transplant 2003, 32(Suppl 1):S57-59.
79. Kreisel W, Potthoff K, Bertz H, et al.: Complete remission of Crohn's disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant 2003, 32:337-340.
80. Garcia-Olmo D, Garcia-Arranz M, Garcia LG, et al.: Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. Int J Colorectal Dis 2003, 18:451-454.